Is Your Lab Ready to Comply with the New Equity Standard?
You’ll need a healthcare equity plan to maintain Joint Commission accreditation after Jan. 1.
Author Information
Glenn S. Demby
Glenn S. Demby is an award-winning journalist with a track record of telling business professionals who aren’t lawyers how to comply with the parts of the law that affect their day-to-day operations. He has expertise in numerous aspects of law including employment, labor, health care, tax, payroll, benefits, and education. He won the Specialized Information Publishing Association’s editorial excellence award four years in a row. A graduate of Columbia University School of Law, he practiced as a corporate lawyer on Wall Street prior to his career as a business-to-business journalist. In addition to overseeing the content of the four G2 Intelligence monthly briefings, he contributes to the daily Laboratory and Pathology Insider.
Posts by the Author
CMS Dishes Out First Penalties for Hospital Price Transparency Violations
After the price transparency rules took effect in January 2021, CMS finally issued the first penalties for violations.
Eight New CLIA-Waived Tests Your Lab Staff Need to Know About
CMS has instructed its MACs to recognize eight new CLIA-waived complexity tests for which labs will be allowed to bill, effective Oct. 1.
Arrayit President Convicted of Silicon Valley Blood Testing Scam
Mark Schena was convicted of swindling investors and running a $77 million kickback scheme involving COVID-19 and allergy tests.
US Government Suspends Free At-Home COVID-19 Antigen Test Program
Biden administration blames the decision on Congress’ failure to provide the additional funding necessary to keep the program going.
Final Surprise Billing Regulations Cut Insurer Control—Sort Of
It remains far from clear whether the new surprise billing rule goes far enough to fix the problem of insurers having too much power in disputes.
FDA to Issue EUA for Monkeypox Tests
The agency will also allow CLIA labs to use serology and antigen tests without EUA.
FDA to Issue Emergency Use Authorization for Monkeypox Tests
In a move to expand access to lab testing for monkeypox, HHS has authorized the FDA to issue EUAs for in vitro diagnostic tests for the virus.
Medicare Part B to Cover New CLIA-Waived Tests on Oct. 1
Make sure your lab billing staff is aware of the changes to ensure full reimbursement.
Rebounds in Core Lab Services Offset Declines in COVID-19 Test Revenues
Second quarter diagnostics earnings were down, but not as much as predicted.
